CN202
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CN202, covering 2021-08-31 to 2021-08-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies [Phase 1, Phase 2]